Novo Nordisk A/S (NYSE:NVO)

58.40
Delayed Data
As of 4:03pm ET
 +0.76 / +1.32%
Today’s Change
41.72
Today|||52-Week Range
59.37
+38.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line1.3B1.1B1.1B1.5B
 
 
 
 
 
Depreciation------98.5M
 
 
Total Other Cash Flow538.7M903.4M-412.9M-530.2M
 
 
 
 
 
Funds From Operations1.8B2.0B1.2B1.0B
 
 
 
 
 
Funds From/For Other Operating Expenses331.5M-131.1M-37.6M425.4M
 
 
 
 
 
Net Cash Flow - Operating Activities1.5B2.2B1.2B609.9M
 
 
 
 
 
 
InvestingDecrease In Investments185.3M-5.2M-810.3K49.5M
 
 
 
 
 
Capital Expenditures-150.2M-171.3M-257.9M-113.9M
 
 
 
 
 
Fixed Asset Disposal2.6M-2.9M347.1K342.6M
 
 
 
 
 
Other Investing - Uses0.000.00-61.2M0.00
 
 
Other Investing - Sources0.0010.5M-10.5M0.00
 
 
 
Net Cash Flow Investing24.2M-188.7M-277.7M273.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-631.2M-696.2M-646.3M-564.3M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-3.7M33.5M44.0M-1.9B
 
 
 
 
 
Other Sources - Financing-385.7M0.000.00347.6M
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-1.0B-662.8M-602.2M-2.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash6.3M2.8M471.6K19.3M
 
 
 
 
 
 
Net Change In Cash498.1M1.3B323.7M-1.3B
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account